...
search icon
  • Apple, Inc AAPL
  • S&P 500 ETF Trust SPDR SPY
  • Alphabet Inc. - Class A Shares GOOGL
  • Microsoft Corporation MSFT
  • Meta Platforms Inc META
  • Netflix, Inc. NFLX
  • Amazon.com Inc. AMZN
  • Spotify Technology SA SPOT
    immp-img

    Immutep Ltd ADR, Common Stock

    IMMP

    NMQ

    $1.815

    +$0.02

    (1.12%)

    1D
    Industry: Biotechnology Sector: Health Care

    Analyst Forecast

    Overview Returns Financials Ratios News FAQs

    Price Chart

    Key Metrics

    Market Cap info-icon
    This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
     $262.75M
    P/E Ratio info-icon
    This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
     0
    Volume info-icon
    This is the total number of shares traded during the most recent trading day.
     14.29K
    Avg Volume info-icon
    This is the average number of shares traded during the most recent 30 days.
     0
    Dividend Yield info-icon
    This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
     0.00%
    Beta info-icon
    This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
     1.41
    52-week Range info-icon
    This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
    $1.32 L
    $2.71 H
    $1.815

    About Immutep Ltd ADR, Common Stock

    Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on LAG-3 immune control mechanism for the treatment of different types of cancers. The company's product pipeline also includes TACTI-004, which is in phase III clinical trial for the treatment of first line non-small cell lung cancer (1L NSCLC); TACTI-003, which is in phase IIb clinical trial to treat first line head and neck squamous cell carcinoma (HNSCC); INSIGHT-005 which is in phase I for metastatic urothelial carcinoma; TACTI-002, which in phase II trial for the treatment NSCLC and HNSCC; AIPAC-003, which is in phase II/III clinical trial to treat metatastic breast cancer; and EFTISARC-NEO, which is in phase II clinical trial for the treatment of soft tissue sarcoma. It also develops INSIGHT-003, which is in phase I trial 1L non squamous NSCL; INSIGHT-005 that is in phase I to treat metastatic urothelial cancer; IMP761, which is in phase I Trial to treat autoimmune disease; IMP731 for oncology and autoimmune diseases; and LAG525. Immutep has collaboration with Merck & Co., Inc., EOC Pharma, Novartis, and Laboratory Corporation of America Holdings. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. The company was incorporated in 1987 and is based in Sydney, Australia. more

    Industry: BiotechnologySector: Health Care

    Returns

    Time FrameIMMPSectorS&P500
    1-Week Return4.68%-0.53%-0.75%
    1-Month Return11.18%-1.11%2.87%
    3-Month Return9.15%0.82%7.41%
    6-Month Return1.7%-6.92%18.72%
    1-Year Return-19%-11.76%15.63%
    3-Year Return11.18%10.67%83.01%
    5-Year Return6.55%30.9%99.85%
    10-Year Return-57.38%109.46%253.9%

    Financials

    Jun '20Jun '21Jun '22Jun '23Jun '245YR TREND
    Total Revenue7.49M3.97M170.37K3.51M3.84M[{"date":"2020-06-30","value":100,"profit":true},{"date":"2021-06-30","value":53,"profit":true},{"date":"2022-06-30","value":2.28,"profit":true},{"date":"2023-06-30","value":46.83,"profit":true},{"date":"2024-06-30","value":51.32,"profit":true}]
    Cost of Revenue22.47M2.07M2.06M2.06M41.55M[{"date":"2020-06-30","value":54.09,"profit":true},{"date":"2021-06-30","value":4.98,"profit":true},{"date":"2022-06-30","value":4.97,"profit":true},{"date":"2023-06-30","value":4.96,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
    Gross Profit(14.99M)1.90M(1.89M)1.44M(37.70M)[{"date":"2020-06-30","value":-789.57,"profit":false},{"date":"2021-06-30","value":100,"profit":true},{"date":"2022-06-30","value":-99.74,"profit":false},{"date":"2023-06-30","value":76.07,"profit":true},{"date":"2024-06-30","value":-1986.54,"profit":false}]
    Gross Margin(200.18%)47.83%(1111.18%)41.19%(981.42%)[{"date":"2020-06-30","value":-418.51,"profit":false},{"date":"2021-06-30","value":100,"profit":true},{"date":"2022-06-30","value":-2323.11,"profit":false},{"date":"2023-06-30","value":86.11,"profit":true},{"date":"2024-06-30","value":-2051.82,"profit":false}]
    Operating Expenses22.56M19.66M34.01M42.88M50.40M[{"date":"2020-06-30","value":44.76,"profit":true},{"date":"2021-06-30","value":39,"profit":true},{"date":"2022-06-30","value":67.48,"profit":true},{"date":"2023-06-30","value":85.07,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
    Operating Income(16.02M)(19.56M)(33.94M)(44.94M)(88.10M)[{"date":"2020-06-30","value":-1601888200,"profit":false},{"date":"2021-06-30","value":-1956057700,"profit":false},{"date":"2022-06-30","value":-3393755400,"profit":false},{"date":"2023-06-30","value":-4493703000,"profit":false},{"date":"2024-06-30","value":-8810418600,"profit":false}]
    Total Non-Operating Income/Expense2.74M1.87M1.82M5.96M49.24M[{"date":"2020-06-30","value":5.56,"profit":true},{"date":"2021-06-30","value":3.8,"profit":true},{"date":"2022-06-30","value":3.69,"profit":true},{"date":"2023-06-30","value":12.1,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
    Pre-Tax Income(13.47M)(29.90M)(32.21M)(39.90M)(42.72M)[{"date":"2020-06-30","value":-1346819500,"profit":false},{"date":"2021-06-30","value":-2990259100,"profit":false},{"date":"2022-06-30","value":-3221079200,"profit":false},{"date":"2023-06-30","value":-3989634800,"profit":false},{"date":"2024-06-30","value":-4271662500,"profit":false}]
    Income Taxes37.0033.0034.002.002.00[{"date":"2020-06-30","value":100,"profit":true},{"date":"2021-06-30","value":89.19,"profit":true},{"date":"2022-06-30","value":91.89,"profit":true},{"date":"2023-06-30","value":5.41,"profit":true},{"date":"2024-06-30","value":5.41,"profit":true}]
    Income After Taxes(13.47M)(29.90M)(32.21M)(39.90M)(42.72M)[{"date":"2020-06-30","value":-1346823200,"profit":false},{"date":"2021-06-30","value":-2990262400,"profit":false},{"date":"2022-06-30","value":-3221082600,"profit":false},{"date":"2023-06-30","value":-3989635000,"profit":false},{"date":"2024-06-30","value":-4271662700,"profit":false}]
    Income From Continuous Operations(13.47M)(29.90M)(46.82M)(39.90M)(42.72M)[{"date":"2020-06-30","value":-1346823200,"profit":false},{"date":"2021-06-30","value":-2990262400,"profit":false},{"date":"2022-06-30","value":-4682423354,"profit":false},{"date":"2023-06-30","value":-3989634800,"profit":false},{"date":"2024-06-30","value":-4271662500,"profit":false}]
    Income From Discontinued Operations-----[{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
    Net Income(13.47M)(29.90M)(32.21M)(39.90M)(42.72M)[{"date":"2020-06-30","value":-1346823200,"profit":false},{"date":"2021-06-30","value":-2990262400,"profit":false},{"date":"2022-06-30","value":-3221082600,"profit":false},{"date":"2023-06-30","value":-3989634800,"profit":false},{"date":"2024-06-30","value":-4271662500,"profit":false}]
    EPS (Diluted)(0.03)(0.40)-(0.30)(0.18)[{"date":"2020-06-30","value":-3.05,"profit":false},{"date":"2021-06-30","value":-40.04,"profit":false},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":-30.26,"profit":false},{"date":"2024-06-30","value":-18,"profit":false}]

    Ratios

    Liquidity

    These ratios help you determine the liquidity of the company. Higher is better.

    IMMP
    Cash Ratio 17.29
    Current Ratio 18.86

    Asset Efficiency

    These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

    IMMP
    ROA (LTM) -22.66%
    ROE (LTM) -36.88%

    Liabilities

    These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

    IMMP
    Debt Ratio Lower is generally better. Negative is bad. 0.05
    Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.95

    Valuation

    These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

    IMMP
    Trailing PE NM
    Forward PE 7.65
    P/S (TTM) 50.06
    P/B 2.67
    EV/R 803.42
    EV/Ebitda NM

    Discover more

    Tsla

    Tesla, Inc.
    aaple

    Apple, Inc.
    GOOGL

    Alphabet Inc. - Class A Shares
    META

    Meta Platforms Inc
    AMZN

    Amazon.com Inc.
    Microsoft

    Microsoft Corporation
    NVDA

    NVIDIA Corporation
    BRK

    Berkshire Hathaway Inc. Hld B
    LLY

    Eli Lilly and Company

    FAQs

    What is Immutep Ltd ADR share price today?

    Immutep Ltd ADR (IMMP) share price today is $1.815

    Can Indians buy Immutep Ltd ADR shares?

    Yes, Indians can buy shares of Immutep Ltd ADR (IMMP) on Vested. To buy Immutep Ltd ADR from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IMMP stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

    Can Fractional shares of Immutep Ltd ADR be purchased?

    Yes, you can purchase fractional shares of Immutep Ltd ADR (IMMP) via the Vested app. You can start investing in Immutep Ltd ADR (IMMP) with a minimum investment of $1.

    How to invest in Immutep Ltd ADR shares from India?

    You can invest in shares of Immutep Ltd ADR (IMMP) via Vested in three simple steps:

    • Click on Sign Up or Invest in IMMP stock at the top of this page
    • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
    • Transfer USD funds to your US Brokerage account and start investing in Immutep Ltd ADR shares
    What is Immutep Ltd ADR 52-week high and low stock price?

    The 52-week high price of Immutep Ltd ADR (IMMP) is $2.71. The 52-week low price of Immutep Ltd ADR (IMMP) is $1.32.

    What is Immutep Ltd ADR price-to-book (P/B) ratio?

    The price-to-book (P/B) ratio of Immutep Ltd ADR (IMMP) is 2.67

    What is the Market Cap of Immutep Ltd ADR?

    The market capitalization of Immutep Ltd ADR (IMMP) is $262.75M

    What is Immutep Ltd ADR’s stock symbol?

    The stock symbol (or ticker) of Immutep Ltd ADR is IMMP

    Feedback

    Signup to access all features and start your US investing journey!

    • Open your account in minutes
    • Take your portfolio global, starting at just $1
    Get started

    Add ticker to compare

    Scroll to Top